We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Clip Closes Arteries From Outside

By HospiMedica staff writers
Posted on 20 Mar 2006
An extravascular closure system developed by Abbott Vascular Devices (Abbot Park, IL, USA) features a nitinol clip designed to achieve a secure closure of the femoral artery access site following diagnostic or interventional vascular procedures. More...
The system has been approved by the U.S. Food and Drug Administration (FDA), following previous approval in many other countries.

The StarClose system consists of the clip applier, clips, and the exchange system. The heart of the system is a circumferential nitinol clip--that provides 360o tissue apposition—
mounted on the applier and delivered through a 5- or 6-French puncture site procedural sheath exchange system used during the intervention. This through-the-sheath (TTS) approach expedites patient management, as extra guide wire insertion and sheath exchange steps are removed from the procedure. Since the same pathway established during the catheterization procedure is used to deliver the clip directly to the puncture site, procedure times are shortened, thereby expediting hemostasis, ambulation, and dischargeability, as well as avoiding potential contamination from contact with the skin.

According to Abbbot, only four clicks of the device are required to achieve a secure extravascular closure. The clip closes the closure site entirely from the outside of the vessel.

The innovative StarClose system provides an original approach to managing vascular access sites, stated Tony Chou, M.D., general manager of the vessel closure technologies section at Abbott Vascular Devices. It incorporates a high degree of confidence in gaining hemostasis, a rapid means of deployment, and it gives physicians a true through-the-sheath approach. StarClose is the result of a focus on clinically beneficial technologies with ground-breaking advances to help the physician and patient to obtain successful procedural outcomes.



Related Links:
Abbott Vascular Devices

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.